angiogenin and Intermittent-Claudication

angiogenin has been researched along with Intermittent-Claudication* in 1 studies

Other Studies

1 other study(ies) available for angiogenin and Intermittent-Claudication

ArticleYear
Angiogenin-A Proposed Biomarker for Cardiovascular Disease-Is Not Associated With Long-Term Survival in Patients With Peripheral Artery Disease.
    Angiology, 2021, Volume: 72, Issue:9

    We evaluated angiogenin as a prospective biomarker in peripheral artery disease (PAD) patients with and without claudication symptoms. A pilot study suggested an elevation of angiogenin in critical limb ischemia. However, in PAD patients, the predictive value of angiogenin has not yet been evaluated. For this purpose, 342 patients with PAD (age: 69 ± 10 years, 34.5% women) were followed-up for 7 years in a cross-sectional study. Angiogenin was measured by enzyme-linked immunosorbent assay. All-cause and cardiovascular mortality were analyzed by Cox regression. Angiogenin levels were higher in men (

    Topics: Aged; Aged, 80 and over; Biomarkers; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Intermittent Claudication; Male; Middle Aged; Peripheral Arterial Disease; Pilot Projects; Predictive Value of Tests; Prognosis; Ribonuclease, Pancreatic; Time Factors

2021